| Literature DB >> 27016316 |
Michael K Lo1, Pei-Yong Shi2, Yen-Liang Chen3, Mike Flint4, Christina F Spiropoulou5.
Abstract
There are currently no antiviral therapies available for the tick-borne flaviviruses associated with hemorrhagic fevers: Kyasanur Forest disease virus (KFDV), both classical and the Alkhurma hemorrhagic fever virus (AHFV) subtype, and Omsk hemorrhagic fever virus (OHFV). In this brief study, we describe the in vitro antiviral activity of adenosine analog NITD008 against KFDV, AHFV, OHFV, as well as Tick-borne Encephalitis virus (TBEV). Alongside the well-established activity of NITD008 against mosquito-borne flaviviruses, our results have demonstrated the feasibility of identifying nucleoside analog inhibitors that have pan-flavivirus activity. Published by Elsevier B.V.Entities:
Keywords: Antiviral; Flavivirus; NITD008; Nucleoside analog; Tick-borne
Mesh:
Substances:
Year: 2016 PMID: 27016316 PMCID: PMC5096641 DOI: 10.1016/j.antiviral.2016.03.013
Source DB: PubMed Journal: Antiviral Res ISSN: 0166-3542 Impact factor: 5.970